CORTENDO AB (PUBL)
Patent Owner
Stats
- 6 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 20, 2018 most recent publication
Details
- 6 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 95 Total Citation Count
- Jun 19, 1998 Earliest Filing
- 5 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9918984 Methods and compositions for treating diabetes, metabolic syndrome and other conditionsApr 01, 16Mar 20, 18[A61K]
7060679 Conformationally constrained backbone cyclized somatostatin analogsAug 12, 04Jun 13, 06[A61K]
6355613 Conformationally constrained backbone cyclized somatostatin analogsDec 02, 98Mar 12, 02[A61K, C07K]
6051554 Conformationally constrained backbone cyclized somatostatin analogsJun 19, 98Apr 18, 00[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0244,436 NOVEL FUNCTIONALIZED 5-(PHENOXYMETHYL)-1,3-DIOXANE ANALOGS EXHIBITING CYTOCHROME P450 INHIBITION AND THEIR METHOD OF USEAbandonedSep 25, 14Aug 25, 16[C07D]
2015/0353,530 NOVEL FUNCTIONALIZED 4-(PHENOXYMETHYL(-1,3-DIOXOLANE ANALOGS EXHIBITING CYTOCHROME P450 INHIBITION AND THEIR METHOD OF USEAbandonedJan 31, 14Dec 10, 15[C07D]
2015/0337,003 ABIRATERONE AND ANALOGS THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH CORTISOL OVERPRODUCTIONAbandonedJan 18, 14Nov 26, 15[C07J]
2015/0210,641 NOVEL CYTOCHROME P450 INHIBITORS AND THEIR METHOD OF USEAbandonedJan 13, 15Jul 30, 15[C07D]
6930088 Conformationally constrained backbone cyclized somatostatin analogsExpiredDec 13, 00Aug 16, 05[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.